Stephan Wullschleger

Stephan Wullschleger has an extensive background in molecular cancer research and precision medicine. With experience at EPFL, MRC Protein Phosphorylation and Ubiquitylation Unit, and Molecular Partners AG, Stephan has honed their skills in in vivo pharmacology, managing outsourced studies, and writing regulatory documents. Stephan's expertise lies in immuno-oncology and translational oncology, making him a valuable asset in the pharmaceutical and research industry.